Literature DB >> 18227764

Antimicrobial resistance of Esherichia coli urinary isolates from primary care patients in Greece.

Matthew E Falagas1, Michael Polemis, Vangelis G Alexiou, Alexandra Marini-Mastrogiannaki, Jeni Kremastinou, Alkiviadis C Vatopoulos.   

Abstract

BACKGROUND: Most of antimicrobial susceptibility surveillance studies focus on isolates from hospitalized patients. A retrospective analysis of microbiological data of the antimicrobial susceptibility of Escherichia coli urinary isolates from primary care patients in Greece was performed here. MATERIAL/
METHODS: The in vitro susceptibility to ampicillin, amoxicillin/clavulanate, cefaclor, cefprozil, trimethoprim-sulfamethoxazole (cotrimoxazole), amikacin, and norfloxacin of 2460 E. coli isolates (01/2005-06/2005) from the urine specimens of patients tested at the laboratories of three Greek primary care diagnostic centers were analyzed. Only the first isolate per patient (2074 females and 386 males) were included in the analysis.
RESULTS: The proportion of E. coli urinary isolates that were resistant to cotrimoxazole was 20.8% and 26.4% for females and males, respectively. There were noteworthy differences between age groups; 37.8% isolates from females <15 years old were resistant to cotrimoxazole compared with 18.9%, 17%, and 23.3% for the 15-35, 35-45, and >55-year-old females, respectively (P<0.001). The proportion of isolates resistant to ampicillin was very high (from 32.1% to 45.3% and 38% to 63% for the urinary isolates from females and males, respectively, in the different age groups examined), while it was relatively low for amikacin (up to 4.1%); 17.8% and 5.5% of the isolates from males and females, respectively, were resistant to norfloxacin (18.2% for males >55 years old).
CONCLUSIONS: These findings offer help to clinicians in deciding the appropriate empirical treatment for primary care patients with urinary tract infection and emphasize the increasing problem of antimicrobial resistance even in the primary care setting in Greece.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18227764

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


  10 in total

1.  Fosfomycin for the treatment of drug-resistant urinary tract infections: potential of an old drug not explored fully.

Authors:  Vrushali Patwardhan; Sarman Singh
Journal:  Int Urol Nephrol       Date:  2017-06-14       Impact factor: 2.370

2.  Antimicrobial susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in health care-associated urinary tract infection: focus on susceptibility to fosfomycin.

Authors:  Yang Hyun Cho; Seung Il Jung; Ho Suck Chung; Ho Song Yu; Eu Chang Hwang; Sun-Ouck Kim; Taek Won Kang; Dong Deuk Kwon; Kwangsung Park
Journal:  Int Urol Nephrol       Date:  2015-05-31       Impact factor: 2.370

3.  Secular trend and risk factors for antimicrobial resistance in Escherichia coli isolates in Switzerland 1997-2007.

Authors:  L Blaettler; D Mertz; R Frei; L Elzi; A F Widmer; M Battegay; U Flückiger
Journal:  Infection       Date:  2009-12       Impact factor: 3.553

4.  ESBLs: A Clear and Present Danger?

Authors:  Rishi H-P Dhillon; John Clark
Journal:  Crit Care Res Pract       Date:  2011-06-06

5.  Characteristics and Antibiotic Resistance of Urinary Tract Pathogens Isolated From Punjab, Pakistan.

Authors:  Muhammad Sohail; Mohsin Khurshid; Hafiz Ghulam Murtaza Saleem; Hasnain Javed; Abdul Arif Khan
Journal:  Jundishapur J Microbiol       Date:  2015-07-25       Impact factor: 0.747

Review 6.  Global prevalence of antibiotic resistance in paediatric urinary tract infections caused by Escherichia coli and association with routine use of antibiotics in primary care: systematic review and meta-analysis.

Authors:  Ashley Bryce; Alastair D Hay; Isabel F Lane; Hannah V Thornton; Mandy Wootton; Céire Costelloe
Journal:  BMJ       Date:  2016-03-15

7.  Nitrofurantoin and Fosfomycin for Extended Spectrum Beta-lactamases Producing Escherichia coli and Klebsiella pneumoniae.

Authors:  Neeraj Kumar Tulara
Journal:  J Glob Infect Dis       Date:  2018 Jan-Mar

8.  Prevalence of antimicrobial resistant Escherichia coli from patients with suspected urinary tract infection in primary care, Denmark.

Authors:  Gloria Córdoba; Anne Holm; Frank Hansen; Anette M Hammerum; Lars Bjerrum
Journal:  BMC Infect Dis       Date:  2017-10-10       Impact factor: 3.090

9.  In vitro effect of fosfomycin on multi-drug resistant gram-negative bacteria causing urinary tract infections.

Authors:  Pallam Gopichand; Girija Agarwal; Mailan Natarajan; Jharna Mandal; Surendran Deepanjali; Sreejith Parameswaran; L N Dorairajan
Journal:  Infect Drug Resist       Date:  2019-07-09       Impact factor: 4.003

10.  Study of Culture and Sensitivity Patterns of Urinary Tract Infections in Patients Presenting with Urinary Symptoms in a Tertiary Care Hospital.

Authors:  Muhammad Muzammil; Muhammad Adnan; Sheikh Muhammad Sikandar; Muhammad Umar Waheed; Naseem Javed; Muhammad Fazal Ur Rehman
Journal:  Cureus       Date:  2020-02-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.